Axim Biotechnologies annual revenue
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Axim Biotechnologies Revenue Growth & History (AXIM)
Axim Biotechnologies reported $70,458 in revenue for fiscal 2024, an increase of 78.29% from the previous fiscal year.
View full Axim Biotechnologies company overviewAxim Biotechnologies annual revenue and growth
| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2024 | 2024-12-31 | $70,458 | $30,940 | +78.29% |
| 2023 | 2023-12-31 | $39,518 | $30,643 | +345.27% |
| 2022 | 2022-12-31 | $8,875 | −$51,585 | −85.32% |
| 2021 | 2021-12-31 | $60,460 | $60,460 | — |
| 2020 | 2020-12-31 | $0 | −$799,483 | −100.00% |
| 2019 | 2019-12-31 | $799,483 | $603,869 | +308.70% |
| 2018 | 2018-12-31 | $195,614 | $148,041 | +311.19% |
| 2017 | 2017-12-31 | $47,573 | $514 | +1.09% |
| 2016 | 2016-12-31 | $47,059 | −$2,080 | −4.23% |
| 2015 | 2015-12-31 | $49,139 | $49,139 | — |
| 2014 | 2014-12-31 | $0 | −$21,667 | −100.00% |
| 2013 | 2013-12-31 | $21,667 | −$21,666 | −50.00% |
| 2012 | 2012-12-31 | $43,333 | $33,333 | +333.33% |
| 2011 | 2011-12-31 | $10,000 | — | — |
Axim Biotechnologies quarterly revenue
Q1.11
Q2.11
Q3.11
Q4.11
Q1.12
Q2.12
Q3.12
Q4.12
Q1.13
Q2.13
Q3.13
Q4.13
Q1.14
Q2.14
Q3.14
Q4.14
Q1.15
Q2.15
Q3.15
Q4.15
Q1.16
Q2.16
Q3.16
Q4.16
Q1.17
Q2.17
Q3.17
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q1.25
Q2.25
| Fiscal quarter | Period ended | Revenue | Change | YoY growth |
|---|---|---|---|---|
| Q2 2025 | 2025-06-30 | $0 | −$17,479 | −100.00% |
| Q1 2025 | 2025-03-31 | $0 | −$52,979 | −100.00% |
| Q2 2024 | 2024-06-30 | $17,479 | $7,550 | +76.04% |
| Q1 2024 | 2024-03-31 | $52,979 | $45,582 | +616.22% |
| Q4 2023 | 2023-12-31 | $12,611 | $5,050 | +66.79% |
| Q3 2023 | 2023-09-30 | $9,581 | $8,267 | +629.15% |
| Q2 2023 | 2023-06-30 | $9,929 | $9,929 | — |
| Q1 2023 | 2023-03-31 | $7,397 | $7,397 | — |
| Q4 2022 | 2022-12-31 | $7,561 | $2,752 | +57.23% |
| Q3 2022 | 2022-09-30 | $1,314 | −$6,813 | −83.83% |
| Q2 2022 | 2022-06-30 | $0 | −$14,875 | −100.00% |
| Q1 2022 | 2022-03-31 | $0 | −$32,649 | −100.00% |
| Q4 2021 | 2021-12-31 | $4,809 | $4,809 | — |
| Q3 2021 | 2021-09-30 | $8,127 | $8,127 | — |
| Q2 2021 | 2021-06-30 | $14,875 | $14,875 | — |
| Q1 2021 | 2021-03-31 | $32,649 | $32,649 | — |
| Q4 2020 | 2020-12-31 | $0 | −$782,422 | −100.00% |
| Q3 2020 | 2020-09-30 | $0 | $0 | — |
| Q2 2020 | 2020-06-30 | $0 | $0 | — |
| Q1 2020 | 2020-03-31 | $0 | −$17,061 | −100.00% |
| Q4 2019 | 2019-12-31 | $782,422 | $615,454 | +368.61% |
| Q3 2019 | 2019-09-30 | $0 | −$6,224 | −100.00% |
| Q2 2019 | 2019-06-30 | $0 | −$8,174 | −100.00% |
| Q1 2019 | 2019-03-31 | $17,061 | $2,813 | +19.74% |
| Q4 2018 | 2018-12-31 | $166,968 | $151,511 | +980.21% |
| Q3 2018 | 2018-09-30 | $6,224 | −$3,534 | −36.22% |
| Q2 2018 | 2018-06-30 | $8,174 | $4,436 | +118.67% |
| Q1 2018 | 2018-03-31 | $14,248 | −$4,372 | −23.48% |
| Q4 2017 | 2017-12-31 | $15,457 | $3,244 | +26.56% |
| Q3 2017 | 2017-09-30 | $9,758 | $158 | +1.65% |
| Q2 2017 | 2017-06-30 | $3,738 | −$7,503 | −66.75% |
| Q1 2017 | 2017-03-31 | $18,620 | $4,615 | +32.95% |
| Q4 2016 | 2016-12-31 | $12,213 | −$3,204 | −20.78% |
| Q3 2016 | 2016-09-30 | $9,600 | −$12,010 | −55.58% |
| Q2 2016 | 2016-06-30 | $11,241 | −$871 | −7.19% |
| Q1 2016 | 2016-03-31 | $14,005 | $14,005 | — |
| Q4 2015 | 2015-12-31 | $15,417 | $17,917 | +716.68% |
| Q3 2015 | 2015-09-30 | $21,610 | $21,610 | — |
| Q2 2015 | 2015-06-30 | $12,112 | $12,112 | — |
| Q1 2015 | 2015-03-31 | $0 | −$2,500 | −100.00% |
| Q4 2014 | 2014-12-31 | −$2,500 | $8,333 | +76.92% |
| Q3 2014 | 2014-09-30 | $0 | −$10,833 | −100.00% |
| Q2 2014 | 2014-06-30 | $0 | −$10,834 | −100.00% |
| Q1 2014 | 2014-03-31 | $2,500 | −$8,333 | −76.92% |
| Q4 2013 | 2013-12-31 | −$10,833 | −$21,667 | −199.99% |
| Q3 2013 | 2013-09-30 | $10,833 | $0 | 0.00% |
| Q2 2013 | 2013-06-30 | $10,834 | $1 | +0.01% |
| Q1 2013 | 2013-03-31 | $10,833 | $0 | 0.00% |
| Q4 2012 | 2012-12-31 | $10,834 | $834 | +8.34% |
| Q3 2012 | 2012-09-30 | $10,833 | $10,833 | — |
| Q2 2012 | 2012-06-30 | $10,833 | $10,833 | — |
| Q1 2012 | 2012-03-31 | $10,833 | $10,833 | — |
| Q4 2011 | 2011-12-31 | $10,000 | — | — |
| Q3 2011 | 2011-09-30 | $0 | — | — |
| Q2 2011 | 2011-06-30 | $0 | — | — |
| Q1 2011 | 2011-03-31 | $0 | — | — |
Axim Biotechnologies revenue growth trends
Over the last five reported fiscal years, revenue declined from $799,483 to $70,458, a compound annual decline of 38.48%. Axim Biotechnologies's latest reported quarter, Q2 2025, generated $0 in revenue, a decrease of 100.00% year over year.
About the data
What revenue means
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
Financial data
Standardized company financials
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review Axim Biotechnologies source filings ↗